This is for 2008 -9
(2007 was a year with great hopes and hype, equals a sp about 50p)

Reality now is a sp about 4p

Yet despite a drug failure ( was it?), they have some products that look interesting - not earth-shattering but a decent pipeline AND some CASH - "wow"! the only Q in my mind: Is it close to the sp? I suspect it is! SO, anyone buying is really buying some hollow-cash - let me explain - that's cash you can't touch, looks good, but has no "solid" value. (since you can't spend it etc)
BUT
There are v.few Bio's with Cash compared with Mkt Cap and I think it will only be time before others see this too. I hold from Past (now forgotten) and mostly from recent lows -
This is a FUll-List co, (Isa-able!), so nothing like many other get-rich Bio's - this is "almost" the real thing....unless anyone can say different....go on!

Note: that IF this went to 50p in the next few years, you are looking at a 10-bagger, so put a few in an ISA to protect the upside...for I suspect the downside is pretty securred. It fell c. 5% today on modest selling 2x the Buys. One Buy was for 100-worth; maybe somone buying certificated to attend AGM's which are nice affarirs, but with relatively few PI's - but that's current woeful Markets, isn't it?
Where else can you get an ISA-able 10-bagger (?) for the cash-value?
+Someone will pounce...let's hope...eh?
-DYOR-
These are woeful times!

Well, the investors have "gone Away" it seems - Currently 14p despite Sales more than expected..... Wow... So just how little was expected?
Others have suggested the sp 90p was too high - an understatement, - but pres. built on HOPE that the American Marketing would fix all.
New Cough product launched late 2015 . . . ?
I think I need something stronger, right now.
EDIT (22Dec2017)-sp 8p [down after AGM,], but this represents the Co-cash near-enough; so the cough mixtures, Etc. are in for v.little.
EDIT (14March2018) - sp~4p2 DYOR. - Looks like there is something wrong here -